Eprosartan
Clinical data | |
---|---|
Trade names | Teveten |
AHFS/Drugs.com | Monograph |
MedlinePlus | a601237 |
License data |
|
Pregnancy category |
|
Routes of administration | By mouth |
ATC code | |
Legal status | |
Legal status | |
Pharmacokinetic data | |
Bioavailability | 15% (Eprosartan mesylate) |
Metabolism | not metabolized |
Elimination half-life | 5 to 9 hours |
Excretion | Kidney 10%, bile duct 90% |
Identifiers | |
| |
JSmol) | |
| |
| |
(verify) |
Eprosartan, sold under the brand name Teveten among others, is an
angiotensin II receptor antagonist used for the treatment of high blood pressure.[1]
Eprosartan is sometimes paired with hydrochlorothiazide.[2]
As with other angiotensin II receptor antagonists, eprosartan is generally better tolerated than enalapril (an ACE inhibitor), especially among the elderly.[3]
History
The compound came into the
Biovail Corporation.[4]
References
- ^ "Eprosartan mesylate- eprosartan mesylate tablet, film coated". DailyMed. Retrieved 7 June 2023.
- ^ "Teveten HCT- eprosartan mesylate and hydrochlorothiazide tablet". DailyMed. 3 January 2012. Retrieved 7 June 2023.
- S2CID 13063704.
- ^ Anon., 2006, Abbott Laboratories: Kos Pharmaceuticals a wise buy, Datamonitor ResearchStore (online), November 8, 2006, see [1], accessed 29 January 2015.